FDA Inspection 971669 — Agila Corporation
The FDA completed an inspection of Agila Corporation on May 24, 2016 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2016
- Fiscal Year
- 2016
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Minneapolis, MN (United States)